CA Patent

CA2801061A1 — Benzoquinolone inhibitors of vmat2

Assigned to Auspex Pharmaceuticals Inc · Expires 2011-12-08 · 14y expired

What this patent protects

The present invention relates to new benzoquinolone inhibitors of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.Formula (I)

USPTO Abstract

The present invention relates to new benzoquinolone inhibitors of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.Formula (I)

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CA2801061A1
Jurisdiction: CA
Classification: —
Expires: 2011-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Auspex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.